Publications scientifiques

European Society of Cardiology quality indicators for the care and outcomes of adults with pulmonary arterial hypertension. Developed in collaboration with the Heart Failure Association of the European Society of Cardiology.

Auteurs : Aktaa S, Gale CP, Brida M, Giannakoulas G, Kovacs G, Adir Y, Benza RL, Böhm M, Coats A, D'Alto M, Escribano-Subias P, Ferrari P, Galiè N, Gibbs JSR, Gin-Sing W, Hoeper MM, Humbert M, Lang IM, Maron BA, Meszaros G, Vonk Noordegraaf A, Price LC, Pepke-Zaba J, Rådegran G, Reis A, Sitbon O, Torbicki A, Ulrich S, Rosenkranz S, Delcroix M.

Sources : Eur J Heart Fail. 2023 Apr;25(4):469-477.

[Physiopathology and treatment of pulmonary arterial hypertension].

Auteurs : Perros F, Jutant ÉM, Savale L, Dorfmüller P, Humbert M, Montani D.

Sources : Med Sci (Paris). 2023 Apr;39(4):359-369.

Molecular Function and Contribution of TBX4 in Development and Disease.

Auteurs : Karolak JA, Welch CL, Mosimann C, Bzdęga K, West JD, Montani D, Eyries M, Mullen MP, Abman SH, Prapa M, Gräf S, Morrell NW, Hemnes AR, Perros F, Hamid R, Logan MPO, Whitsett J, Galambos C, Stankiewicz P, Chung WK, Austin ED.

Sources : Am J Respir Crit Care Med. 2023 Apr 1;207(7):855-864.

Efficacy and safety of methylprednisolone pulse followed by oral prednisone vs. oral prednisone alone in sarcoidosis tubulointerstitial nephritis: a randomized, open-label, controlled clinical trial.

Auteurs : Mahevas M, Audard V, Rousseau A, Cez A, Guerrot D, Verhelst D, Delahousse M, Hanrotel C, Pillebout E, Daugas E, Krastinova E, Valeyre D, Boffa JJ; GSF French Sarcoidosis Group.

Sources : Nephrol Dial Transplant. 2023 Mar 31;38(4):961-968.

[Hepatopulmonary syndrome].

Auteurs : Sayadi A, Duhaut L, Robert F, Savale L, Coilly A.

Sources : Rev Med Interne. 2023 Mar 31:S0248-8663(23)00113-3.

Management of nontuberculous mycobacteria in lung transplant cases: an international Delphi study.

Auteurs : Asif H, Rahaghi FF, Ohsumi A, Philley J, Emtiazjoo A, Hirama T, Baker AW, Shu CC, Silveira F, Poulin V, Rizzuto P, Nagao M, Burgel PR, Hays S, Aksamit T, Kawasaki T, Dela Cruz C, Aliberti S, Nakajima T, Ruoss S, Marras TK, Snell GI, Winthrop K, Mirsaeidi M.

Sources : ERJ Open Res. 2023 Mar 27;9(2):00377-2022.

Long-term Outcome of Children with Newly Diagnosed Pulmonary Arterial Hypertension: Results From the Global TOPP-registry.

Auteurs : Ploegstra MJ, Dunbar Ivy D, Beghetti M, Bonnet D, Alehan D, Ablonczy L, Mattos S, Bowers D, Humpl T, Berger RMF; TOPP Investigators.

Sources : Eur Heart J Qual Care Clin Outcomes. 2023 Mar 27:qcad020.

Pulmonary arterial compliance and exercise capacity after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension.

Auteurs : Sermet R, Piliero N, Guillien A, Madoun S, Doutreleau S, Salvat M, Finas M, Thony F, Vautrin E, Bouvaist H, Degano B.

Sources : ERJ Open Res. 2023 Mar 27;9(2):00590-2022.

No increased prevalence of autoantibodies neutralizing type I IFNs in idiopathic pulmonary fibrosis patients.

Auteurs : No increased prevalence of autoantibodies neutralizing type I IFNs in idiopathic pulmonary fibrosis patients.

Sources : Respir Res. 2023 Mar 20;24(1):87.

Pharmaceutical Oral Formulation of Methionine as a Pediatric Treatment in Inherited Metabolic Disease.

Auteurs : Querin B, Schweitzer-Chaput A, Cisternino S, Auvity S, Fauqueur AS, Negbane A, Hadchouel A, Schlatter J, Cotteret C.

Sources : Pharmaceutics. 2023 Mar 16;15(3):957.